Michael applies significant experience in biomedical engineering and immunology to help clients develop strategic patent portfolios. He works with a wide range of early-stage and established biotechnology and medical device companies on the drafting and prosecution of patent applications. He also assists with IP due diligence through the evaluation of client and competitor portfolios.
An accomplished scientist, Michael’s research focused on nanomaterial effects on the immune system. His studies in nanoparticle synthesis, characterization, and downstream in-vitro and in-vivo analyses equip him with technical expertise in materials science, conjugation chemistries, cell culture, immunoassays, and in-vivo imaging.
As part of his research studies, Michael:
- Investigated mechanisms of immunological toxicity associated with metal oxide nanoparticles
- Developed nanoparticle-based therapies for autoimmunity
- Investigated various nano-encapsulated molecules for their ability to enhance regulatory T cells in mouse models, using polymeric and liposomal biodegradable nanoparticle platforms
- Studied the optimization of cell-targeting specificity by high-avidity antibody conjugation to nanoparticle surfaces
Michael has co-authored original research articles in peer-reviewed journals, such as Nanotoxicology and Biomaterials.
- Federation of Clinical Immunology Society (FOCIS) Trainee Award
- AJ Drexel Scholarship
- Contributor, Yale Daily News
- Member, Federation of Clinical Immunology Scientists
- Member, American Association for the Advancement of Science
- Member, Biomedical Engineering Society